BIOMARKERS OF FIBROSIS IN ADULTS WITH REPAIRED TETRALOGY OF FALLOT  by Hogberg, Ingrid et al.
Congenital Cardiology Solutions
E845
JACC March 27, 2012
Volume 59, Issue 13
BIOMARKERS OF FIBROSIS IN ADULTS WITH REPAIRED TETRALOGY OF FALLOT
ACC Moderated Poster Contributions
McCormick Place South, Hall A
Sunday, March 25, 2012, 11:00 a.m.-Noon
Session Title: Congenital Cardiology Solutions: Adult IV
Abstract Category: 29. Congenital Cardiology Solutions: Adult
Presentation Number: 1143-403
Authors: Ingrid Hogberg, C. Bohun, Joseph Weiss, Craig Broberg, Oregon Health & Science Univ., Portland, OR, USA
Background: Patients with tetralogy of fallot (TOF) develop exercise intolerance, reduced ejection fraction, elevated brain-natriuretic peptide, and 
evidence of myocardial fibrosis. Elevation of biomarkers associated with fibrogenesis would confirm this as a mechanism of heart failure.
Methods: Consecutive adults with repaired TOF (N=31, 45% female) and healthy controls (N=21) were evaluated prospectively with magnetic 
resonance, echocardiography, 6-minute walk test (6MWT) and blood tests. Biomarkers of fibrogenesis were quantified and compared between 
groups.
Results: While not different in age or body mass index, TOF patients had lower LV ejection fraction (63±9 vs. 68±6%, p=0.01), RV ejection fraction 
(53±8 vs. 62±6%, p<0.001), 6MWT distance (488±123 vs. 642±81m, p<0.001), and higher brain natriuretic peptide (80±63 vs. 19±10, p<0.001) 
compared to controls. In contrast, there was no difference in PCINP (54±27 vs. 44±16 mcg/l), PCIIINP (3.2±1.1 vs. 2.9±0.06mcg/l), aldosterone 
(172±53 vs. 181±67pg/ml), MMP-2 (190±36 vs. 182±27ng/ml), or TIMP-1 (135±22 vs. 127±28ng/ml). There was no correlation between these 
biomarkers and age, ejection fraction, RVEDV, or walk distance.
Conclusions: Despite evidence of cardiovascular dysfunction, biomarkers of fibrosis were not abnormal. Alternative mechanisms associated with 
myocardial dysfunction should be considered.
Results
Tetralogy 
(N=31) 
Controls 
(N=21)
Tetralogy 
(N=31)
Controls 
(N=21) 
Variables Mean SD Mean SD P-Value Biomarkers Mean ± SD Mean ± SD P-Value
Age (years) 39.3 ±13.7 38.7 ±11.8 0.8790 Aldosterone (pg/ml) 172 ±53 181 ±67 0.58
Walk Distance (m) 488 ±123 642 ±81 0.0000
Pro-collagen I NT 
(mcg/l)
54.0 ±27.4 44.2 ±16.4 0.15
LV ejection fraction 
(%)
62.7 ±8.8 68.5 ±6.5 0.0132
Pro-collagen III NT 
(mcg/l)
3.2 ±1.1 2.9 ±0.6 0.21
RV ejection 
fraction (%)
52.5 ±7.8 61.7 ±5.6 0.0000 MMP-2 (ng/ml) 190 ±36 182 ±27 0.37
RV end-diastolic 
volume (ml/m2)
128.4 ±43.7 87.1 ±15.1 0.0001 TIMP-1 (ng/ml) 136 ±22 128 ±28 0.26
Brain natriuretic 
peptide
80.9 ±64.0 19.6 ±10.2 0.0001
